Literature DB >> 1672446

Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells.

P Hasty1, R Ramírez-Solis, R Krumlauf, A Bradley.   

Abstract

Gene targeting in embryonic stem (ES) cells is a powerful tool for generating mice with null alleles. Current methods of gene inactivation in ES cells introduce a neomycin gene (neo) cassette both as a mutagen and a selection marker for transfected cells. Although null alleles are valuable, changes at the nucleotide level of a gene are very important for functional analysis. One gene family in which subtle mutations would be particularly valuable are the clusters of Hox homeobox genes. Inactivation of gene in a cluster with a neo cassette that includes promoter/enhancer elements may deregulate transcription of neighbouring genes and generate a phenotype which is difficult to interpret. We describe here a highly efficient gene targeting method, termed the 'hit and run' procedure. This generates ES cells with subtle site-specific mutations with no selectable marker and may be useful for most genes. We have developed this procedure at the hypoxanthine phosphoribosyltransferase (hprt) locus and subsequently isolated ES cells with a premature stop codon in the homeobox of Hox-2.6 (ref. 14).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672446     DOI: 10.1038/350243a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  81 in total

1.  Factors affecting the efficiency of introducing precise genetic changes in ES cells by homologous recombination: tag-and-exchange versus the Cre-loxp system.

Authors:  J C Vazquez; C Nogues; E B Rucker; J A Piedrahita
Journal:  Transgenic Res       Date:  1998-05       Impact factor: 2.788

Review 2.  Modification and repression of genes expressed in the mammary gland using gene targeting and other technologies.

Authors:  J L Vilotte; P L'Huillier; J C Mercier
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-07       Impact factor: 2.673

Review 3.  Gene targeting in the mouse: advances in introduction of transgenes into the genome by homologous recombination.

Authors:  Ravi P Misra; Stephen A Duncan
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

4.  Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo.

Authors:  P P Lakhlani; L B MacMillan; T Z Guo; B A McCool; D M Lovinger; M Maze; L E Limbird
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

5.  Disruption of the cystic fibrosis transmembrane conductance regulator gene in embryonic stem cells by gene targeting.

Authors:  R Ratcliff; M J Evans; J Doran; B J Wainwright; R Williamson; W H Colledge
Journal:  Transgenic Res       Date:  1992-07       Impact factor: 2.788

6.  Gene repeat expansion and contraction by spontaneous intrachromosomal homologous recombination in mammalian cells.

Authors:  Leah R Read; Steven J Raynard; Ania Rukść; Mark D Baker
Journal:  Nucleic Acids Res       Date:  2004-02-20       Impact factor: 16.971

7.  The nucleotide sequence of greA, a suppressor gene that restores growth of an Escherichia coli RNA polymerase mutant at high temperature.

Authors:  J Sparkowski; A Das
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

Review 8.  Cardiac-specific inducible and conditional gene targeting in mice.

Authors:  Thomas Doetschman; Mohamad Azhar
Journal:  Circ Res       Date:  2012-05-25       Impact factor: 17.367

9.  The Anti-nptII Gene (A Potential Negative Selectable Marker for Plants).

Authors:  C. Xiang; D. J. Guerra
Journal:  Plant Physiol       Date:  1993-05       Impact factor: 8.340

10.  Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting.

Authors:  Youfei Guan; Yahua Zhang; Jing Wu; Zhonghua Qi; Guangrui Yang; Dou Dou; Yuansheng Gao; Lihong Chen; Xiaoyan Zhang; Linda S Davis; Mingfeng Wei; Xuefeng Fan; Monica Carmosino; Chuanming Hao; John D Imig; Richard M Breyer; Matthew D Breyer
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.